Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.38666 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.51571 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.51415 | 71 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.18528 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.50679 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.55758 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.51815 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.43667 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.18082 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.50877 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.26733 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.49321 | 71 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.25824 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.25709 | 69 |